Piramal Pharma (BOM:543635) Marketable Securities : ₹2,863 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Piramal Pharma's Marketable Securities for the quarter that ended in Mar. 2024 was ₹2,863 Mil.

Piramal Pharma's annual Marketable Securities increased from Mar. 2022 (₹1,513 Mil) to Mar. 2023 (₹5,391 Mil) but then declined from Mar. 2023 (₹5,391 Mil) to Mar. 2024 (₹2,863 Mil).

Piramal Pharma Marketable Securities Historical Data

The historical data trend for Piramal Pharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Marketable Securities Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Marketable Securities

156.40

1,512.90

5,390.80

2,863.20

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial							5,390.80	-	4,138.10	-	2,863.20

Piramal Pharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Piramal Pharma (BOM:543635) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Piramal Pharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (BOM:543635) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » Marketable Securities

Traded in Other Exchanges

PPLPHARMA:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (BOM:543635) Headlines

No Headlines